Volume 29, Number 3—March 2023
Research Letter
Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults
Figure
![Seroprevalence of smallpox vaccine–generated antibodies among older adults, Spain. Detectable vaccinia virus antibody levels in the different age groups analyzed and for the total study population are given.](/eid/images/22-1231-F1.jpg)
Figure. Seroprevalence of smallpox vaccine–generated antibodies among older adults, Spain. Detectable vaccinia virus antibody levels in the different age groups analyzed and for the total study population are given.
1These senior authors contributed equally to this article.
Page created: December 31, 2022
Page updated: February 20, 2023
Page reviewed: February 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.